{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:42:41Z","timestamp":1775011361415,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12325-020-01541-5","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T07:07:52Z","timestamp":1604646472000},"page":"521-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus Study"],"prefix":"10.1007","volume":"38","author":[{"given":"Jesper R\u00f8mhild","family":"Davidsen","sequence":"first","affiliation":[]},{"given":"Jelle","family":"Miedema","sequence":"additional","affiliation":[]},{"given":"Wim","family":"Wuyts","sequence":"additional","affiliation":[]},{"given":"Maritta","family":"Kilpel\u00e4inen","sequence":"additional","affiliation":[]},{"given":"Spyridon","family":"Papiris","sequence":"additional","affiliation":[]},{"given":"Effrosyni","family":"Manali","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Robalo Cordeiro","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Morais","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9578-743X","authenticated-orcid":false,"given":"Montse","family":"P\u00e9rez","sequence":"additional","affiliation":[]},{"given":"Guus","family":"Asijee","sequence":"additional","affiliation":[]},{"given":"David","family":"Cendoya","sequence":"additional","affiliation":[]},{"given":"St\u00e9phane","family":"Soulard","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"issue":"10","key":"1541_CR1","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/rheumatology\/keh671","volume":"44","author":"FA Wollheim","year":"2005","unstructured":"Wollheim FA. Classification of systemic sclerosis. Vis Real Rheumatol. 2005;44(10):1212\u20136.","journal-title":"Vis Real Rheumatol"},{"issue":"8","key":"1541_CR2","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/art.38702","volume":"66","author":"EL Herzog","year":"2014","unstructured":"Herzog EL, Mathur A, Tager AM, Feghali-Bostwick C, Schneider F, Varga J. Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheumatol. 2014;66(8):1967\u201378.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1541_CR3","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s10067-018-4182-3","volume":"37","author":"JG Royle","year":"2018","unstructured":"Royle JG, Lanyon PC, Grainge MJ, Abhishek A, Pearce FA. The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink. Clin Rheumatol. 2018;37(8):2103\u201311.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1541_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semarthrit.2018.11.002","volume":"49","author":"LA Garc\u00eda Rodr\u00edguez","year":"2019","unstructured":"Garc\u00eda Rodr\u00edguez LA, Gonz\u00e1lez-P\u00e9rez A, Michel A, S\u00e1ez ME. Contemporary epidemiology of systemic sclerosis: a population-based cohort study in the United Kingdom. Semin Arthritis Rheum. 2019;49(1):105\u201311.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"1541_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1752-699X.2010.00228.x","volume":"6","author":"M De Santis","year":"2012","unstructured":"De Santis M, Bosello SL, Peluso G, Pinnelli M, Alivernini S, Zizzo G, et al. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease. Clin Respir J. 2012;6(1):9\u201317.","journal-title":"Clin Respir J"},{"issue":"8","key":"1541_CR6","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","volume":"71","author":"FMP Meier","year":"2012","unstructured":"Meier FMP, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2012;71(8):1355\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1541_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/rheumatology\/keh124","volume":"43","author":"RJ Allcock","year":"2004","unstructured":"Allcock RJ, Forrest I, Corris PA, Crook PR, Griffiths ID. A study of the prevalence of systemic sclerosis in northeast England. Rheumatology. 2004;43(5):596\u2013602.","journal-title":"Rheumatology"},{"issue":"5","key":"1541_CR8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.semarthrit.2004.09.001","volume":"34","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Tsifetaki N, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA, et al. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum. 2005;34(5):714\u201320.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"1541_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MD.0b013e318189372f","volume":"87","author":"MC Arias-Nu\u00f1ez","year":"2008","unstructured":"Arias-Nu\u00f1ez MC, Llorca J, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Martin J, et al. Systemic sclerosis in Northwestern Spain: a 19-year epidemiologic study. Medicine (Baltimore). 2008;87(5):272\u201380.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1541_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.semarthrit.2012.10.001","volume":"42","author":"H El Adssi","year":"2013","unstructured":"El Adssi H, Cirstea D, Virion J-M, Guillemin F, de Korwin J-D. Estimating the prevalence of systemic sclerosis in the Lorraine region, France, by the capture\u2013recapture method. Semin Arthritis Rheum. 2013;42(5):530\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1541_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/ard.2008.091710","volume":"68","author":"MC Vonk","year":"2009","unstructured":"Vonk MC, Broers B, Heijdra YF, Ton E, Snijder R, van Dijk APJ, et al. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study. Ann Rheum Dis. 2009;68(6):961\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1541_CR12","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/annrheumdis-2013-203618","volume":"73","author":"K Andr\u00e9asson","year":"2014","unstructured":"Andr\u00e9asson K, Saxne T, Bergknut C, Hesselstrand R, Englund M. Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria. Ann Rheum Dis. 2014;73(10):1788\u201392.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1541_CR13","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/rheumatology\/kes076","volume":"51","author":"A-M Hoffmann-Vold","year":"2012","unstructured":"Hoffmann-Vold A-M, Midtvedt \u00d8, Molberg \u00d8, Garen T, Gran JT. Prevalence of systemic sclerosis in south-east Norway. Rheumatology. 2012;51(9):1600\u20135.","journal-title":"Rheumatology"},{"key":"1541_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41927-018-0043-6","volume":"2","author":"SA Butt","year":"2018","unstructured":"Butt SA, Jeppesen JL, Fuchs C, Mogensen M, Engelhart M, Torp-Pedersen C, et al. Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study. BMC Rheumatol. 2018;2:36.","journal-title":"BMC Rheumatol"},{"issue":"10","key":"1541_CR15","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Air\u00f2 P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69(10):1809\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1541_CR16","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u201347.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1541_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-019-0980-7","volume":"20","author":"V Cottin","year":"2019","unstructured":"Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res. 2019;20(1):1\u201310.","journal-title":"Respir Res"},{"issue":"11","key":"1541_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NSL Goh","year":"2008","unstructured":"Goh NSL, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis. Am J Respir Crit Care Med. 2008;177(11):1248\u201354.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"1541_CR19","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76(8):1327\u201339.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1541_CR20","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"DP Tashkin","year":"2016","unstructured":"Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016;4(9):708\u201319.","journal-title":"Lancet Respir Med"},{"issue":"26","key":"1541_CR21","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Stowasser S, et al. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med. 2019;380(26):2518\u201328.","journal-title":"N Engl J Med."},{"key":"1541_CR22","first-page":"20","volume":"20","author":"WA Wuyts","year":"2020","unstructured":"Wuyts WA, Papiris S, Manali E, Kilpel\u00e4inen M, Davidsen JR, Miedema J, et al. The burden of progressive fibrosing interstitial lung disease: A DELPHI approach. Adv Ther. 2020;20:20.","journal-title":"Adv Ther."},{"issue":"5","key":"1541_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0016-3287(69)80025-X","volume":"1","author":"N Dalkey","year":"1969","unstructured":"Dalkey N. An experimental study of group opinion: the Delphi method. Futures. 1969;1(5):408\u201326.","journal-title":"Futures"},{"issue":"6","key":"1541_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.rmed.2008.12.019","volume":"103","author":"T Suda","year":"2009","unstructured":"Suda T, Kaida Y, Nakamura Y, Enomoto N, Hashimoto D, Takehara Y, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med [Internet]. 2009;103(6):846\u201353. https:\/\/doi.org\/10.1016\/j.rmed.2008.12.019.","journal-title":"Respir Med [Internet]"},{"key":"1541_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis an international working group report. Am J Respir Criti Care Med. 2016;194:265\u201375.","journal-title":"Am J Respir Criti Care Med"},{"issue":"2","key":"1541_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","volume":"44","author":"M Rubio-Rivas","year":"2014","unstructured":"Rubio-Rivas M, Royo C, Sime\u00f3n CP, Corbella X, Fonollosa V. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(2):208\u201319.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"1541_CR27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis. 2007;66(7):940\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1541_CR28","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","volume":"43","author":"VD Steen","year":"2000","unstructured":"Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43(11):2437\u201344.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1541_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.autrev.2017.09.010","volume":"16","author":"A Fischer","year":"2017","unstructured":"Fischer A, Zimovetz E, Ling C, Esser D, Schoof N. Humanistic and cost burden of systemic sclerosis: A review of the literature. Autoimmun Rev. 2017;16(11):1147\u201354.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1541_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3109\/03009742.2014.976653","volume":"44","author":"K Chevreul","year":"2015","unstructured":"Chevreul K, Brigham KB, Gandr\u00e9 C, Mouthon L, Serrano-Aguilar P, Linertov\u00e1 R, et al. The economic burden and health-related quality of life associated with systemic sclerosis in France. Scand J Rheumatol. 2015;44(3):238\u201346.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"1541_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/art.24086","volume":"61","author":"S Bernatsky","year":"2009","unstructured":"Bernatsky S, Hudson M, Panopalis P, Clarke AE, Pope J, LeClercq S, et al. The cost of systemic sclerosis. Arthritis Care Res. 2009;61(1):119\u201323.","journal-title":"Arthritis Care Res"},{"key":"1541_CR32","first-page":"S150","volume":"36","author":"F Basta","year":"2018","unstructured":"Basta F, Afeltra A, Margiotta DPE. Fatigue in systemic sclerosis: a systematic review. Clin Exp Rheumatol. 2018;36:S150\u201360.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1541_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5606\/ArchRheumatol.2019.7111","volume":"34","author":"C March","year":"2019","unstructured":"March C, Huscher D, Preis E, Makowka A, Hoeppner J, Buttgereit F, et al. Prevalence, risk factors and assessment of depressive symptoms in patients with systemic sclerosis. Arch Rheumatol. 2019;34(3):253\u201361.","journal-title":"Arch Rheumatol"},{"issue":"1","key":"1541_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-57636-0","volume":"10","author":"C Foocharoen","year":"2020","unstructured":"Foocharoen C, Chunlertrith K, Mairiang P, Mahakkanukrauh A, Suwannaroj S, Namvijit S, et al. Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study. Sci Rep [Internet]. 2020;10(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-020-57636-0.","journal-title":"Sci Rep [Internet]"},{"issue":"12","key":"1541_CR35","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.3899\/jrheum.120600","volume":"39","author":"DE Furst","year":"2012","unstructured":"Furst DE, Fernandes AW, Iorga SR, Greth W, Bancroft TIM. Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured population. J Rheumatol. 2012;39(12):2303\u20139.","journal-title":"J Rheumatol"},{"issue":"2","key":"1541_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3899\/jrheum.170307","volume":"45","author":"A Fischer","year":"2018","unstructured":"Fischer A, Kong AM, Swigris JJ, Cole AL, Raimundo K. All-cause healthcare costs and mortality in patients with systemic sclerosis with lung involvement. J Rheumatol. 2018;45(2):235\u201341.","journal-title":"J Rheumatol"},{"issue":"5","key":"1541_CR37","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s12325-019-00929-2","volume":"36","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Fan Y, Thomason D, Tang W, Liu X, Zhou ZY, et al. Economic burden of illness among commercially insured patients with systemic sclerosis with interstitial lung disease in the USA: a claims data analysis. Adv Ther. 2019;36(5):1100\u201313.","journal-title":"Adv Ther"},{"key":"1541_CR38","first-page":"1","volume":"20","author":"K Morrisroe","year":"2019","unstructured":"Morrisroe K, Stevens W, Sahhar J, Ngian G, Ferdowsi N, Hansen D, et al. The clinical and economic burden of systemic sclerosis related interstitial lung disease. Rheumatology. 2019;20:1\u201311.","journal-title":"Rheumatology"},{"key":"1541_CR39","first-page":"1","volume":"2019","author":"P Singh","year":"2018","unstructured":"Singh P, Thakur B, Kumar A, Prasanta M. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: a single-center study from India. Int J Rheum Dis. 2018;2019:1\u20135.","journal-title":"Int J Rheum Dis"},{"key":"1541_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1620\/tjem.239.297","volume":"20","author":"F Tomiyama","year":"2016","unstructured":"Tomiyama F, Watanabe R, Ishii T, Kamogawa Y, Fujita Y, Shirota Y, et al. High prevalence of acute exacerbation of interstitial lung disease in Japanese patients with systemic sclerosis. Tohoku J Exp Med. 2016;20:297\u2013305.","journal-title":"Tohoku J Exp Med"},{"key":"1541_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000329893","volume":"0046","author":"R Tachikawa","year":"2012","unstructured":"Tachikawa R, Tomii K, Ueda H, Nagata K, Nanjo S, Sakurai A, et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration. 2012;0046:20\u20137.","journal-title":"Respiration"},{"issue":"4","key":"1541_CR42","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","volume":"32","author":"F Hasson","year":"2000","unstructured":"Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008\u201315.","journal-title":"J Adv Nurs."},{"issue":"2","key":"1541_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.2042-7174.1996.tb00844.x","volume":"4","author":"J Cantrill","year":"1996","unstructured":"Cantrill J, Sibblald B, Buetow S. The Delphi and nominal group techniques in health services. Int J Pharm Pract. 1996;4(2):67\u201374.","journal-title":"Int J Pharm Pract"},{"issue":"10","key":"1541_CR44","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1177\/0961203314532699","volume":"23","author":"M Petri","year":"2014","unstructured":"Petri M, Bechtel B, Dennis G, Shah M, McLaughlin T, Kan H, et al. Burden of corticosteroid use in patients with systemic lupus erythematosus: Results from a Delphi panel. Lupus. 2014;23(10):1006\u201313.","journal-title":"Lupus"},{"issue":"1","key":"1541_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-015-0038-9","volume":"4","author":"X Yu","year":"2015","unstructured":"Yu X, Chen S, Chen X, Jia J, Li C, Liu C, et al. Clinical management and associated costs for moderate and severe Alzheimer\u2019s disease in urban China: a Delphi panel study. Transl Neurodegener [Internet]. 2015;4(1):1\u20139. https:\/\/doi.org\/10.1186\/s40035-015-0038-9.","journal-title":"Transl Neurodegener [Internet]"},{"issue":"3","key":"1541_CR46","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00127-004-0729-5","volume":"39","author":"C Ferri","year":"2004","unstructured":"Ferri C, Chisholm D, Van Ommeren M, Prince M. Resource utilisation for neuropsychiatric disorders in developing countries: a multinational Delphi consensus study. Soc Psychiatry Psychiatr Epidemiol. 2004;39(3):218\u201327.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"2","key":"1541_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3810\/hp.2012.04.978","volume":"40","author":"F Xie","year":"2012","unstructured":"Xie F, Hopkins R, Burke N, Tarride JE, Goeree R. Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: a Delphi study. Hosp Pract (1995). 2012;40(2):131\u20137.","journal-title":"Hosp Pract (1995)"},{"issue":"1","key":"1541_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-016-0168-6","volume":"16","author":"F Morell","year":"2016","unstructured":"Morell F, Esser D, Lim J, Stowasser S, Villacampa A, Nieves D, et al. Treatment patterns, resource use and costs of idiopathic pulmonary fibrosis in Spain\u2014results of a Delphi Panel. BMC Pulm Med [Internet]. 2016;16(1):1\u20139. https:\/\/doi.org\/10.1186\/s12890-016-0168-6.","journal-title":"BMC Pulm Med [Internet]"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01541-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-020-01541-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01541-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T16:38:56Z","timestamp":1697042336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-020-01541-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1541"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01541-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"9 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}